Cutler Group LP Actinium Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$9.71 - $12.51 $143,708 - $185,148	-14,800 Reduced 83.15%	3,000 $0
Q3 2022 Oct 25, 2022	BUY	$4.81 - $8.48 $72,150 - $127,200	15,000 Added 535.71%	17,800 $6,000
Q2 2022 Aug 04, 2022	SELL	$4.71 - $7.11 $51,810 - $78,210	-11,000 Reduced 79.71%	2,800 $0
Q1 2022 Apr 14, 2022	BUY	$4.57 - $6.4 $40,216 - $56,320	8,800 Added 176.0%	13,800 $4,000
Q4 2021 Jan 18, 2022	BUY	$6.01 - $8.8 $30,050 - $44,000	5,000 New	5,000 $4,000

6.65M

369K

148K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $176M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.